or Try an Advanced Search...

    Technical Analysis for SAVA - Cassava Sciences, Inc.

    Grade Last Price % Change Price Change
    C 32.18 23.53% 6.13
    SAVA closed up 23.53 percent on Thursday, November 21, 2024, on 2.53 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    6 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical SAVA trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    MACD Bullish Centerline Cross Bullish 0.00%
    180 Bullish Setup Bullish Swing Setup 0.00%
    Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Range Bar Range Expansion 0.00%
    Multiple of Ten Bullish Other 0.00%
    BB Squeeze Ended Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Older End-of-Day Signals for SAVA ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 4 hours ago
    1.5x Volume Pace about 5 hours ago
    Possible Pocket Pivot about 5 hours ago
    Up 2 ATRs about 5 hours ago
    Up 10% about 5 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SAVA Chart by TradingView
    Basic chart:

    Profile

    Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Psychiatric Diagnosis Psychiatry Nervous System Disorders Abnormal Psychology Transdermal

    Is SAVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Cassava taps Freda Nassif as chief commercial officer as simufilam Phase 3 readout nears
    Nov 18 Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
    Nov 15 Cassava Sciences updates on Phase 3 Alzheimer’s trial ahead of key readout
    Nov 15 Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year?
    Nov 12 What Makes Cassava Sciences (SAVA) a New Buy Stock
    Nov 11 Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
    Nov 8 Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla?
    Nov 8 Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting
    Nov 7 Cassava Sciences: Pivotal Alzheimer's Data May Push Stock Toward Book Value
    Nov 7 Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh
    See more SAVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.2
    52 Week Low 8.79
    Average Volume 1,827,659
    200-Day Moving Average 22.95
    50-Day Moving Average 27.59
    20-Day Moving Average 26.61
    10-Day Moving Average 27.28
    Average True Range 2.46
    RSI (14) 64.79
    ADX 13.56
    +DI 33.66
    -DI 15.16
    Chandelier Exit (Long, 3 ATRs) 26.61
    Chandelier Exit (Short, 3 ATRs) 30.83
    Upper Bollinger Bands 29.73
    Lower Bollinger Band 23.50
    Percent B (%b) 1.39
    BandWidth 23.38
    MACD Line 0.34
    MACD Signal Line -0.14
    MACD Histogram 0.4791
    Fundamentals Value
    Market Cap 1.36 Billion
    Num Shares 42.2 Million
    EPS -2.29
    Price-to-Earnings (P/E) Ratio -14.05
    Price-to-Sales 0.00
    Price-to-Book 6.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 44.11
    Resistance 3 (R3) 43.38 38.68 42.12
    Resistance 2 (R2) 38.68 35.64 39.04 41.45
    Resistance 1 (R1) 35.43 33.77 37.06 36.16 40.79
    Pivot Point 30.73 30.73 31.54 31.09 30.73
    Support 1 (S1) 27.48 27.69 29.11 28.21 23.57
    Support 2 (S2) 22.78 25.82 23.14 22.91
    Support 3 (S3) 19.53 22.78 22.24
    Support 4 (S4) 20.26